# Nucor Corp: financial statements, quarterly

NUE · NYSE · CIK 73309 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nue.md) · [Financials](/companies/nue/financials.md) · [Filings](/companies/nue/filings.md) · [Insiders](/companies/nue/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nue/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-04-05) | Q2 FY2025 (2025-07-05) | Q3 FY2025 (2025-10-04) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [8.8](/filings/0000950170-25-028427.md) | [7.7](/filings/0000950170-25-028427.md) | [8.1](/filings/0000950170-25-071567.md) | [8.1](/filings/0000950170-25-107646.md) | [7.4](/filings/0001193125-25-276207.md) | [7.1](/filings/0000950170-25-028427.md) | [7.8](/filings/0001193125-26-220778.md) | [8.5](/filings/0001193125-26-345891.md) | [8.5](/filings/0001193125-25-276207.md) | [7.7 d](/filings/0001193125-26-071575.md) | [9.5](/filings/0001193125-26-220778.md) | [10.4](/filings/0001193125-26-345891.md) |
| Cost of revenue | $bn | [6.9](/filings/0000950170-24-121863.md) | [6.3 d](/filings/0001193125-26-071575.md) | [6.6](/filings/0000950170-25-071567.md) | [6.9](/filings/0000950170-25-107646.md) | [6.7](/filings/0001193125-25-276207.md) | [6.4 d](/filings/0001193125-26-071575.md) | [7.2](/filings/0001193125-26-220778.md) | [7.2](/filings/0001193125-26-345891.md) | [7.3](/filings/0001193125-25-276207.md) | [6.8 d](/filings/0001193125-26-071575.md) | [8.0](/filings/0001193125-26-220778.md) | [8.4](/filings/0001193125-26-345891.md) |
| Gross profit | $bn | [1.9](/filings/0000950170-25-028427.md) | [1.4](/filings/0000950170-25-028427.md) | [1.5](/filings/0000950170-25-028427.md) | [1.2](/filings/0000950170-25-028427.md) | [0.8](/filings/0000950170-25-028427.md) | [0.6](/filings/0000950170-25-028427.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $bn | [0.4](/filings/0000950170-24-121863.md) | [0.4 d](/filings/0001193125-26-071575.md) | [0.3](/filings/0000950170-25-071567.md) | [0.3](/filings/0000950170-25-107646.md) | [0.2](/filings/0001193125-25-276207.md) | [0.2 d](/filings/0001193125-26-071575.md) | [0.3](/filings/0001193125-26-220778.md) | [0.3](/filings/0001193125-26-345891.md) | [0.3](/filings/0001193125-25-276207.md) | [0.3 d](/filings/0001193125-26-071575.md) | [0.4](/filings/0001193125-26-220778.md) | [0.4](/filings/0001193125-26-345891.md) |
| Interest expense | $bn | [0.1](/filings/0000950170-24-121863.md) | [0.1 d](/filings/0001193125-26-071575.md) | [0.0](/filings/0000950170-25-071567.md) | [0.1](/filings/0000950170-25-107646.md) | [0.1](/filings/0001193125-25-276207.md) | [0.1 d](/filings/0001193125-26-071575.md) | [0.1](/filings/0001193125-26-220778.md) | [0.0](/filings/0001193125-26-345891.md) | [0.0](/filings/0001193125-25-276207.md) | [0.0 d](/filings/0001193125-26-071575.md) | [0.0](/filings/0001193125-26-220778.md) | [0.0](/filings/0001193125-26-345891.md) |
| Income tax | $bn | [0.3](/filings/0000950170-24-121863.md) | [0.2 d](/filings/0001193125-26-071575.md) | [0.3](/filings/0000950170-25-071567.md) | [0.2](/filings/0000950170-25-107646.md) | [0.1](/filings/0001193125-25-276207.md) | [0.0 d](/filings/0001193125-26-071575.md) | [0.1](/filings/0001193125-26-220778.md) | [0.2](/filings/0001193125-26-345891.md) | [0.2](/filings/0001193125-25-276207.md) | [0.1 d](/filings/0001193125-26-071575.md) | [0.2](/filings/0001193125-26-220778.md) | [0.3](/filings/0001193125-26-345891.md) |
| Net income | $bn | [1.1](/filings/0000950170-25-028427.md) | [0.8](/filings/0000950170-25-028427.md) | [0.8](/filings/0000950170-25-071567.md) | [0.6](/filings/0000950170-25-107646.md) | [0.3](/filings/0001193125-25-276207.md) | [0.3](/filings/0000950170-25-028427.md) | [0.2](/filings/0001193125-26-220778.md) | [0.6](/filings/0001193125-26-345891.md) | [0.6](/filings/0001193125-25-276207.md) | [0.4 d](/filings/0001193125-26-071575.md) | [0.7](/filings/0001193125-26-220778.md) | [1.2](/filings/0001193125-26-345891.md) |
| Diluted EPS | $ per share | [4.57](/filings/0000950170-25-028427.md) | [3.16](/filings/0000950170-25-028427.md) | [3.46](/filings/0000950170-25-071567.md) | [2.68](/filings/0000950170-25-107646.md) | [1.05](/filings/0001193125-25-276207.md) | [1.22](/filings/0000950170-25-028427.md) | [0.67](/filings/0001193125-26-220778.md) | [2.60](/filings/0001193125-26-345891.md) | [2.63](/filings/0001193125-25-276207.md) | not reported | [3.23](/filings/0001193125-26-220778.md) | [5.04](/filings/0001193125-26-345891.md) |
| Basic EPS | $ per share | [4.58](/filings/0000950170-25-028427.md) | [3.17](/filings/0000950170-25-028427.md) | [3.46](/filings/0000950170-25-071567.md) | [2.68](/filings/0000950170-25-107646.md) | [1.05](/filings/0001193125-25-276207.md) | [1.22](/filings/0000950170-25-028427.md) | [0.67](/filings/0001193125-26-220778.md) | [2.60](/filings/0001193125-26-345891.md) | [2.63](/filings/0001193125-25-276207.md) | not reported | [3.23](/filings/0001193125-26-220778.md) | [5.05](/filings/0001193125-26-345891.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-04-05) | Q2 FY2025 (2025-07-05) | Q3 FY2025 (2025-10-04) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [5.9](/filings/0000950170-23-060729.md) | [6.4](/filings/0000950170-25-028427.md) | [4.6](/filings/0000950170-24-055144.md) | [4.6](/filings/0000950170-24-092479.md) | [4.3](/filings/0000950170-24-121863.md) | [3.6](/filings/0001193125-26-071575.md) | [3.2](/filings/0000950170-25-071567.md) | [1.9](/filings/0000950170-25-107646.md) | [2.2](/filings/0001193125-25-276207.md) | [2.3](/filings/0001193125-26-345891.md) | [2.2](/filings/0001193125-26-220778.md) | [2.5](/filings/0001193125-26-345891.md) |
| Current assets | $bn | [15.9](/filings/0000950170-23-060729.md) | [16.4](/filings/0000950170-25-028427.md) | [14.6](/filings/0000950170-24-055144.md) | [14.3](/filings/0000950170-24-092479.md) | [13.5](/filings/0000950170-24-121863.md) | [12.5](/filings/0001193125-26-071575.md) | [12.8](/filings/0000950170-25-071567.md) | [11.7](/filings/0000950170-25-107646.md) | [11.8](/filings/0001193125-25-276207.md) | [11.8](/filings/0001193125-26-345891.md) | [12.1](/filings/0001193125-26-220778.md) | [13.2](/filings/0001193125-26-345891.md) |
| Total assets | $bn | [34.3](/filings/0000950170-23-060729.md) | [35.3](/filings/0001193125-26-071575.md) | [33.9](/filings/0000950170-24-055144.md) | [34.2](/filings/0000950170-24-092479.md) | [34.3](/filings/0000950170-24-121863.md) | [33.9](/filings/0001193125-26-071575.md) | [34.7](/filings/0000950170-25-071567.md) | [34.2](/filings/0000950170-25-107646.md) | [34.8](/filings/0001193125-25-276207.md) | [35.1](/filings/0001193125-26-345891.md) | [35.6](/filings/0001193125-26-220778.md) | [37.0](/filings/0001193125-26-345891.md) |
| Current liabilities | $bn | [4.3](/filings/0000950170-23-060729.md) | [4.6](/filings/0000950170-25-028427.md) | [3.6](/filings/0000950170-24-055144.md) | [4.9](/filings/0000950170-24-092479.md) | [5.2](/filings/0000950170-24-121863.md) | [5.0](/filings/0001193125-26-071575.md) | [5.1](/filings/0000950170-25-071567.md) | [4.1](/filings/0000950170-25-107646.md) | [4.3](/filings/0001193125-25-276207.md) | [4.0](/filings/0001193125-26-345891.md) | [4.2](/filings/0001193125-26-220778.md) | [5.2](/filings/0001193125-26-345891.md) |
| Total liabilities | $bn | [12.8](/filings/0000950170-23-060729.md) | [13.2](/filings/0000950170-25-028427.md) | [12.2](/filings/0000950170-24-055144.md) | [12.4](/filings/0000950170-24-092479.md) | [12.8](/filings/0000950170-24-121863.md) | [12.5](/filings/0001193125-26-071575.md) | [13.6](/filings/0000950170-25-071567.md) | [12.7](/filings/0000950170-25-107646.md) | [12.8](/filings/0001193125-25-276207.md) | [13.0](/filings/0001193125-26-345891.md) | [13.1](/filings/0001193125-26-220778.md) | [13.7](/filings/0001193125-26-345891.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | [0.1](/filings/0000950170-25-028427.md) | not reported | not reported | not reported | [1.0](/filings/0001193125-26-071575.md) | not reported | not reported | not reported | [0.1](/filings/0001193125-26-071575.md) | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0000950170-23-060729.md) | [0.1](/filings/0000950170-25-028427.md) | [0.1](/filings/0000950170-24-055144.md) | [0.2](/filings/0000950170-24-092479.md) | [0.2](/filings/0000950170-24-121863.md) | [0.2](/filings/0001193125-26-071575.md) | [0.2](/filings/0000950170-25-071567.md) | [0.2](/filings/0000950170-25-107646.md) | [0.1](/filings/0001193125-25-276207.md) | [0.1](/filings/0001193125-26-345891.md) | [0.1](/filings/0001193125-26-220778.md) | [0.1](/filings/0001193125-26-345891.md) |
| Shareholders' equity | $bn | [20.5](/filings/0000950170-23-060729.md) | [20.9](/filings/0000950170-25-028427.md) | [20.7](/filings/0000950170-24-055144.md) | [20.7](/filings/0000950170-24-092479.md) | [20.5](/filings/0000950170-24-121863.md) | [20.3](/filings/0001193125-26-071575.md) | [20.1](/filings/0000950170-25-071567.md) | [20.4](/filings/0000950170-25-107646.md) | [20.8](/filings/0001193125-25-276207.md) | [20.9](/filings/0001193125-26-345891.md) | [21.5](/filings/0001193125-26-220778.md) | [22.1](/filings/0001193125-26-345891.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-04-05) | Q2 FY2025 (2025-07-05) | Q3 FY2025 (2025-10-04) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,464 d](/filings/0000950170-24-121863.md) | [1,520 d](/filings/0001193125-26-071575.md) | [460](/filings/0000950170-25-071567.md) | [1,485 d](/filings/0000950170-25-107646.md) | [1,301 d](/filings/0001193125-25-276207.md) | [733 d](/filings/0001193125-26-071575.md) | [364](/filings/0001193125-26-220778.md) | [732 d](/filings/0001193125-26-345891.md) | [1,339 d](/filings/0001193125-25-276207.md) | [799 d](/filings/0001193125-26-071575.md) | [886](/filings/0001193125-26-220778.md) | [1,400 d](/filings/0001193125-26-345891.md) |
| Capital expenditure | $m | [439 d](/filings/0000950170-24-121863.md) | [718 d](/filings/0001193125-26-071575.md) | [670](/filings/0000950170-25-071567.md) | [801 d](/filings/0000950170-25-107646.md) | [823 d](/filings/0001193125-25-276207.md) | [879 d](/filings/0001193125-26-071575.md) | [859](/filings/0001193125-26-220778.md) | [954 d](/filings/0001193125-26-345891.md) | [807 d](/filings/0001193125-25-276207.md) | [802 d](/filings/0001193125-26-071575.md) | [661](/filings/0001193125-26-220778.md) | [571 d](/filings/0001193125-26-345891.md) |
| Dividends paid | $m | [128 d](/filings/0000950170-24-121863.md) | [127 d](/filings/0001193125-26-071575.md) | [134](/filings/0000950170-25-071567.md) | [130 d](/filings/0000950170-25-107646.md) | [130 d](/filings/0001193125-25-276207.md) | [128 d](/filings/0001193125-26-071575.md) | [129](/filings/0001193125-26-220778.md) | [129 d](/filings/0001193125-26-345891.md) | [127 d](/filings/0001193125-25-276207.md) | [127 d](/filings/0001193125-26-071575.md) | [129](/filings/0001193125-26-220778.md) | [129 d](/filings/0001193125-26-345891.md) |
| Share repurchases | $m | [500 d](/filings/0000950170-24-121863.md) | [177 d](/filings/0001193125-26-071575.md) | [1,001](/filings/0000950170-25-071567.md) | [500 d](/filings/0000950170-25-107646.md) | [400 d](/filings/0001193125-25-276207.md) | [316 d](/filings/0001193125-26-071575.md) | [300](/filings/0001193125-26-220778.md) | [200 d](/filings/0001193125-26-345891.md) | [100 d](/filings/0001193125-25-276207.md) | [100 d](/filings/0001193125-26-071575.md) | [125](/filings/0001193125-26-220778.md) | [350 d](/filings/0001193125-26-345891.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q3 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-04-05) | Q2 FY2025 (2025-07-05) | Q3 FY2025 (2025-10-04) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [260](/filings/0000950170-23-060729.md) | [254](/filings/0000950170-24-055144.md) | [251](/filings/0000950170-24-092479.md) | [249](/filings/0000950170-24-121863.md) | [244](/filings/0000950170-25-071567.md) | [240](/filings/0000950170-25-107646.md) | [237](/filings/0001193125-25-276207.md) | [233](/filings/0001193125-26-220778.md) | [231](/filings/0001193125-26-345891.md) | [230](/filings/0001193125-25-276207.md) | [229](/filings/0001193125-26-220778.md) | [229](/filings/0001193125-26-345891.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 226,875,676 at 2026-07-04, from the cover of the [10-Q filed 2026-08-12](/filings/0001193125-26-345891.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.